Cargando…
Allosteric inhibition reveals SHP2-mediated tumor immunosuppression in colon cancer by single-cell transcriptomics
Colorectal cancer (CRC), a malignant tumor worldwide consists of microsatellite instability (MSI) and stable (MSS) phenotypes. Although SHP2 is a hopeful target for cancer therapy, its relationship with innate immunosuppression remains elusive. To address that, single-cell RNA sequencing was perform...
Autores principales: | Gao, Jian, Wu, Zhigui, Zhao, Mingxia, Zhang, Rui, Li, Manru, Sun, Dongdong, Cheng, Haibo, Qi, Xianjia, Shen, Yuxian, Xu, Qiang, Chen, Hongqi, Chen, Dijun, Sun, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802865/ https://www.ncbi.nlm.nih.gov/pubmed/35127377 http://dx.doi.org/10.1016/j.apsb.2021.08.006 |
Ejemplares similares
-
Allosteric inhibition of SHP2 uncovers aberrant TLR7 trafficking in aggravating psoriasis
por: Zhu, Yuyu, et al.
Publicado: (2021) -
Selective inhibition of leukemia-associated SHP2(E69K) mutant by the allosteric SHP2 inhibitor SHP099
por: Sun, X, et al.
Publicado: (2018) -
Impact of SHP2 tyrosine phosphorylation on the development of acquired resistance to allosteric SHP2 inhibitors
por: Franciosa, Giulia, et al.
Publicado: (2023) -
Mechanism of activating mutations and allosteric drug inhibition of the phosphatase SHP2
por: Pádua, Ricardo A. P., et al.
Publicado: (2018) -
SHP2 deneddylation mediates tumor immunosuppression in colon cancer via the CD47/SIRPα axis
por: Li, Yiqing, et al.
Publicado: (2023)